Regenerative medicine is an emerging field in the healthcare industry concerned with the repair, replacement, and regeneration of damaged human tissue and organs. This includes damage from age-related degeneration, congenital defects, accidents, or diseases.
Regenerative medicine is used in a wide range of applications including neurology, musculoskeletal, cardiovascular, and orthopedic. Earlier this month, a study showed that a new regenerative medicine appears to relieve eye pain, light sensitivity, and burning, and stimulate faster tissue repair following eye surgery. Findings by a team of researchers in Turkey suggest that this new compound can be beneficial for all those patients who undergo refractive surgery and corneal implants.
Get PDF Brochure for more Professional and Technical industry insights: http://bit.ly/2cLP1oT
Regenerative medicine, according to the US National Institutes of Health (NIH), is the process of developing functional tissues for the repair and/or replacement of damaged organs or tissues. Having lost function due to disease, congenital defects, and age, these tissues or organs are regenerated to establish and restore normal function.
Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.
The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.
Ongoing Trends Reflected in the Regenerative Medicine Market
There a number of factors that not only drive or challenge the global regenerative medicine market but also characterize its presence in the overall field of medical science.
- One of the most significant forces working in favor of the regenerative medicine market is technological advancements in stem cell therapy and tissue engineering.
- The prevalence of joint and bone disorders has increased in recent years, fueled by the rise in the aging population, increasing prevalence of arthritis, and surge in sports injuries. This, in turn, has given a boost to the regenerative medicine market.
- Strong demand and presence of favorable reimbursement policies has spurred the development of biomaterials technology, rendering it the largest technology segment of the regenerative medicine market.
- The widening range of applications of tissue engineering in improving or replacing biological functions is anticipated to drive the demand for tissue engineering in the coming years.
- Regenerative medicine is most commonly used in substituting bone grafts and this application segment has flourished owing to the rise in orthopedic surgeries.
- North America serves as the leading regional market for regenerative medicine owing to surging demand for joint and bone reconstructive surgeries and favorable government initiatives.
- Europe, also a major market, is fueled by the rise in geriatric population, which is more prone to arthritis, and extensive funding from the government to support the research and development of regenerative medicine.
- Asia Pacific has been identified as the most promising market for regenerative medicine, driven by the rising demand for bone graft substitutes and expansion of product manufacturers in countries such as China, South Korea, India, and Japan.
View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/regenerative-medicines-market.html
The regenerative medicine market is a rapidly developing segment of medical science and a report by Transparency Market Research indicates that the global regenerative medicine market is poised to expand at a strong CAGR of 12.80% from 2013 to 2019.
Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.